122 related articles for article (PubMed ID: 21542013)
1. Functional relevance of the BMD-associated polymorphism rs312009: novel involvement of RUNX2 in LRP5 transcriptional regulation.
Agueda L; Velázquez-Cruz R; Urreizti R; Yoskovitz G; Sarrión P; Jurado S; Güerri R; Garcia-Giralt N; Nogués X; Mellibovsky L; Díez-Pérez A; Marie PJ; Balcells S; Grinberg D
J Bone Miner Res; 2011 May; 26(5):1133-44. PubMed ID: 21542013
[TBL] [Abstract][Full Text] [Related]
2. A haplotype-based analysis of the LRP5 gene in relation to osteoporosis phenotypes in Spanish postmenopausal women.
Agueda L; Bustamante M; Jurado S; Garcia-Giralt N; Ciria M; Saló G; Carreras R; Nogués X; Mellibovsky L; Díez-Pérez A; Grinberg D; Balcells S
J Bone Miner Res; 2008 Dec; 23(12):1954-63. PubMed ID: 18684085
[TBL] [Abstract][Full Text] [Related]
3. Influence of an LRP5 cytoplasmic SNP on Wnt signaling and osteoblastic differentiation.
Guo J; Cooper LF
Bone; 2007 Jan; 40(1):57-67. PubMed ID: 16956801
[TBL] [Abstract][Full Text] [Related]
4. Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women.
Ezura Y; Nakajima T; Urano T; Sudo Y; Kajita M; Yoshida H; Suzuki T; Hosoi T; Inoue S; Shiraki M; Emi M
Bone; 2007 Apr; 40(4):997-1005. PubMed ID: 17306638
[TBL] [Abstract][Full Text] [Related]
5. Mutations and promoter SNPs in RUNX2, a transcriptional regulator of bone formation.
Napierala D; Garcia-Rojas X; Sam K; Wakui K; Chen C; Mendoza-Londono R; Zhou G; Zheng Q; Lee B
Mol Genet Metab; 2005; 86(1-2):257-68. PubMed ID: 16140555
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta.
Ziros PG; Georgakopoulos T; Habeos I; Basdra EK; Papavassiliou AG
J Bone Miner Res; 2004 Nov; 19(11):1892-904. PubMed ID: 15476590
[TBL] [Abstract][Full Text] [Related]
7. Human estrogen receptor alpha gene is a target of Runx2 transcription factor in osteoblasts.
Lambertini E; Penolazzi L; Tavanti E; Schincaglia GP; Zennaro M; Gambari R; Piva R
Exp Cell Res; 2007 May; 313(8):1548-60. PubMed ID: 17350616
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel protein/DNA interactions within the promoter of the bone-related transcription factor Runx2/Cbfa1.
Drissi H; Pouliot A; Stein JL; van Wijnen AJ; Stein GS; Lian JB
J Cell Biochem; 2002; 86(2):403-12. PubMed ID: 12112009
[TBL] [Abstract][Full Text] [Related]
9. Association of a RUNX2 promoter polymorphism with bone mineral density in postmenopausal Korean women.
Lee HJ; Koh JM; Hwang JY; Choi KY; Lee SH; Park EK; Kim TH; Han BG; Kim GS; Kim SY; Lee JY
Calcif Tissue Int; 2009 Jun; 84(6):439-45. PubMed ID: 19424741
[TBL] [Abstract][Full Text] [Related]
10. Analysis of association of LRP5, LRP6, SOST, DKK1, and CTNNB1 genes with bone mineral density in a Slovenian population.
Mencej-Bedrac S; Prezelj J; Kocjan T; Komadina R; Marc J
Calcif Tissue Int; 2009 Dec; 85(6):501-6. PubMed ID: 19898734
[TBL] [Abstract][Full Text] [Related]
11. Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density.
Urano T; Shiraki M; Ezura Y; Fujita M; Sekine E; Hoshino S; Hosoi T; Orimo H; Emi M; Ouchi Y; Inoue S
J Bone Miner Metab; 2004; 22(4):341-5. PubMed ID: 15221492
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator.
Tamiya H; Ikeda T; Jeong JH; Saito T; Yano F; Jung YK; Ohba S; Kawaguchi H; Chung UI; Choi JY
Gene; 2008 Jun; 416(1-2):53-60. PubMed ID: 18442887
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the osteopontin promoter affect its transcriptional activity.
Giacopelli F; Marciano R; Pistorio A; Catarsi P; Canini S; Karsenty G; Ravazzolo R
Physiol Genomics; 2004 Dec; 20(1):87-96. PubMed ID: 15479859
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men.
Kiel DP; Ferrari SL; Cupples LA; Karasik D; Manen D; Imamovic A; Herbert AG; Dupuis J
Bone; 2007 Mar; 40(3):587-96. PubMed ID: 17137849
[TBL] [Abstract][Full Text] [Related]
15. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter.
Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ
Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492
[TBL] [Abstract][Full Text] [Related]
16. Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck bmd in Spanish postmenopausal women.
Bustamante M; Nogués X; Agueda L; Jurado S; Wesselius A; Cáceres E; Carreras R; Ciria M; Mellibovsky L; Balcells S; Díez-Pérez A; Grinberg D
Calcif Tissue Int; 2007 Oct; 81(4):327-32. PubMed ID: 17878995
[TBL] [Abstract][Full Text] [Related]
17. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.
Kumar J; Swanberg M; McGuigan F; Callreus M; Gerdhem P; Akesson K
Bone; 2011 Sep; 49(3):343-8. PubMed ID: 21645651
[TBL] [Abstract][Full Text] [Related]
18. LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women.
Bollerslev J; Wilson SG; Dick IM; Islam FM; Ueland T; Palmer L; Devine A; Prince RL
Bone; 2005 Apr; 36(4):599-606. PubMed ID: 15777745
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
20. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
